SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Deciphering cellular and viral determinants of lytic HSV-1 infection, latency and reactivation

The DecipherHSV project aims to uncover the molecular mechanisms of HSV-1 infection and latency using advanced computational tools and single-cell RNA sequencing to inform new therapeutic strategies.

Subsidie
€ 1.998.008
2022

Projectdetails

Introduction

Herpes simplex virus 1 (HSV-1) is an important human pathogen that infects the majority of the world's population and inflicts a substantial burden of disease. Over the past 10 years, systems biology approaches, to which my lab has provided seminal contributions, have substantially broadened our understanding of the complex interaction of this common pathogen with its human host.

Knowledge Gaps

However, the underlying molecular mechanisms remain poorly understood, and their importance for virus latency and reactivation remains elusive. Furthermore, currently available technology lacks the temporospatial resolution to decipher the cellular and viral determinants that govern the virus life cycle.

Project Goals

The main goal of DecipherHSV is to close these knowledge and technology gaps and decipher novel mechanisms and their functional interplay by which HSV-1 manipulates its host cells throughout the virus life cycle.

Objectives

Accordingly, the three primary objectives of DecipherHSV are to:

  1. Decipher the full complement of viral elements that govern productive infection.
  2. Decipher how and why HSV-1 manipulates pervasive transcription within the host and viral genome.
  3. Decipher the cellular and viral determinants of HSV-1 latency and reactivation.

Methodology

Alongside, I will develop new computational approaches and integrative analysis tools, and employ artificial intelligence to exploit the wealth of information that is provided by the novel single-cell RNA sequencing approaches, which I will pioneer (Heterogeneity-seq and Perturb-scSLAM-seq).

Expected Outcomes

Thereby, I will deliver new leads for novel therapeutic approaches targeting HSV-1 latency and reactivation. This will provide a paradigm for the study of other herpesviruses and their complex host-pathogen interactions.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.998.008
Totale projectbegroting€ 1.998.008

Tijdlijn

Startdatum1-5-2022
Einddatum30-4-2028
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • MEDIZINISCHE HOCHSCHULE HANNOVERpenvoerder
  • JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG

Land(en)

Germany

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Interplay of CMV with cellular pathways, states and cell types

This project aims to develop advanced tools to investigate HCMV-host interactions, uncover viral protein functions, and identify infection vulnerabilities to enhance therapeutic strategies.

ERC Consolid...€ 2.000.000
2025
Details

Mechanisms of Kaposi's sarcoma herpesvirus replication and maintenance during latency

This project aims to develop an innovative Xenopus egg extract system to study KSHV latency mechanisms, paving the way for targeted therapies against KSHV-related cancers.

ERC Starting...€ 1.494.774
2024
Details

Dynamics and heterogeneity of early viral infection

This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.

ERC Consolid...€ 2.000.000
2023
Details

Endogenous Human Herpesvirus: Germ line integration and effects on host cell and organism

The ENDo-HERPES project aims to investigate the functional impact of integrated HHV-6 on disease development, telomere dynamics, and host cell interactions using advanced technologies.

ERC Consolid...€ 2.000.000
2023
Details

Interrogating RNA-protein interactions underlying SARS-CoV-2 infection and antiviral defense

This project aims to decode RNA-protein interactions in SARS-CoV-2 to understand its replication cycle and identify potential antiviral targets for treating viral diseases.

ERC Starting...€ 1.500.000
2022
Details
ERC Consolid...

Interplay of CMV with cellular pathways, states and cell types

This project aims to develop advanced tools to investigate HCMV-host interactions, uncover viral protein functions, and identify infection vulnerabilities to enhance therapeutic strategies.

ERC Consolidator Grant
€ 2.000.000
2025
Details
ERC Starting...

Mechanisms of Kaposi's sarcoma herpesvirus replication and maintenance during latency

This project aims to develop an innovative Xenopus egg extract system to study KSHV latency mechanisms, paving the way for targeted therapies against KSHV-related cancers.

ERC Starting Grant
€ 1.494.774
2024
Details
ERC Consolid...

Dynamics and heterogeneity of early viral infection

This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.

ERC Consolidator Grant
€ 2.000.000
2023
Details
ERC Consolid...

Endogenous Human Herpesvirus: Germ line integration and effects on host cell and organism

The ENDo-HERPES project aims to investigate the functional impact of integrated HHV-6 on disease development, telomere dynamics, and host cell interactions using advanced technologies.

ERC Consolidator Grant
€ 2.000.000
2023
Details
ERC Starting...

Interrogating RNA-protein interactions underlying SARS-CoV-2 infection and antiviral defense

This project aims to decode RNA-protein interactions in SARS-CoV-2 to understand its replication cycle and identify potential antiviral targets for treating viral diseases.

ERC Starting Grant
€ 1.500.000
2022
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Hacking the ribosome to map virus-host associations

The VirHoX project aims to map virus-host associations using a novel technique, VirHo-seq, to enhance understanding of viral interactions and address challenges posed by emerging pathogens.

EIC Pathfinder€ 3.000.000
2025
Details
EIC Pathfinder

Hacking the ribosome to map virus-host associations

The VirHoX project aims to map virus-host associations using a novel technique, VirHo-seq, to enhance understanding of viral interactions and address challenges posed by emerging pathogens.

EIC Pathfinder
€ 3.000.000
2025
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.